This inventor holds 0 USPTO granted patents, plus 4 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Gary Tollefson: Innovator in Weight Loss Therapy
Introduction
Gary Tollefson was a notable inventor in the field of weight loss therapy, particularly for patients suffering from major depression. His innovative approach combined the use of naltrexone and bupropion to assist overweight or obese individuals dealing with this mental health condition. Although he has passed away, his contributions to medical science continue to be recognized.
Latest Patents
Gary Tollefson's most significant patent application is titled "Methods Of Providing Weight Loss Therapy In Patients With Major Depression." This application focuses on the therapeutic use of naltrexone and bupropion for weight loss in patients diagnosed with major depressive disorder. Despite having no granted patents, his work in this area has laid the groundwork for future research and development.
Career Highlights
Throughout his career, Tollefson was associated with Nalpropion Pharmaceuticals LLC, where he worked on developing innovative therapies aimed at improving the quality of life for patients. His dedication to addressing the intersection of mental health and obesity has made a lasting impact in the medical community.
Collaborations
Tollefson collaborated with various professionals in the field, including his coworker Eduardo Dunayevich. Their combined expertise contributed to the advancement of therapeutic methods that could benefit many patients.
Conclusion
Gary Tollefson's work in weight loss therapy for patients with major depression represents a significant contribution to medical innovation. His legacy continues to inspire future research in this important area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile